CAS 450348-85-3

AVE3085

Produit contrôlé

CAS : 450348-85-3

AVE3085 is a novel drug that inhibits the activity of soluble guanylate cyclase. It has been shown to have a positive effect on cardiac hypertrophy and chronic kidney disease (CKD) by inhibiting the production of reactive oxygen species by pde5 inhibitors and organic nitrates. This drug also has an effect on blood pressure in clinical studies, which may be due to its inhibition of polymerase chain reaction. AVE3085 is currently undergoing phase III clinical trials.

Formule : C₁₆H₁₄FNO

Degré de pureté : Min. 95%

Masse moléculaire : 255.29 g/mol

Ref: 3D-ATA34885

AVE3085

CAS : 450348-85-3

AVE3085 is an enhancer of endothelial nitric oxide synthase that restores endothelial function and lowers blood pressure in spontaneously hypertensive rats.

Formule : C₁₇H₁₃F₂NO₃

Degré de pureté : 99.87%

Couleur et forme : Solid

Masse moléculaire : 317.29

Ref: TM-T14355